The heparanome - The enigma of encoding and decoding heparan sulfate sulfation

Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CLR, Dierks T (2007)
In: Journal of Biotechnology. JOURNAL OF BIOTECHNOLOGY, 129(2). ELSEVIER SCIENCE BV: 290-307.

Konferenzbeitrag | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Lamanna, William C.; Kalus, InaUniBi; Padva, Michael; Baldwin, Rebecca J.; Merry, Catherine L. R.; Dierks, ThomasUniBi
Abstract / Bemerkung
Heparan sulfate (HS) is a cell surface carbohydrate polymer modified with sulfate moieties whose highly ordered composition is central to directing specific cell signaling events. The ability of the cell to generate these information rich glycans with such specificity has opened up a new field of "heparanomics" which seeks to understand the systems involved in generating these cell type and developmental stage specific HS sulfation patterns. Unlike other instances where biological information is encrypted as linear sequences in molecules such as DNA, HS sulfation patterns are generated through a non-template driven process. Thus, deciphering the sulfation code and the dynamic nature of its generation has posed a new challenge to system biologists. The recent discovery of two sulfatases, Sulf1 and Sulf2, with the unique ability to edit sulfation patterns at the cell surface, has opened up a new dimension as to how we understand the regulation of HS sulfation patterning and pattern-dependent cell signaling events. This review will focus on the functional relationship between HS sulfation patterning and biological processes. Special attention will be given to Sulf1 and Sulf2 and how these key editing enzymes might act in concert with the HS biosynthetic enzymes to generate and regulate specific HS sulfation patterns in vivo. We will further explore the use of knock out mice as biological models for understanding the dynamic systems involved in generating HS sulfation patterns and their biological relevance. A brief overview of new technologies and innovations summarizes advances in the systems biology field for understanding non-template molecular networks and their influence on the "heparanome". Published by Elsevier B.V.
Stichworte
sulf knock out; sulf; heparanome; heparan sulfate; glycosaminogiycans; mice; systems biololgy
Erscheinungsjahr
2007
Titel des Konferenzbandes
Journal of Biotechnology
Serien- oder Zeitschriftentitel
JOURNAL OF BIOTECHNOLOGY
Band
129
Ausgabe
2
Seite(n)
290-307
ISSN
0168-1656
Page URI
https://pub.uni-bielefeld.de/record/1594028

Zitieren

Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CLR, Dierks T. The heparanome - The enigma of encoding and decoding heparan sulfate sulfation. In: Journal of Biotechnology. JOURNAL OF BIOTECHNOLOGY. Vol 129. ELSEVIER SCIENCE BV; 2007: 290-307.
Lamanna, W. C., Kalus, I., Padva, M., Baldwin, R. J., Merry, C. L. R., & Dierks, T. (2007). The heparanome - The enigma of encoding and decoding heparan sulfate sulfation. Journal of Biotechnology, JOURNAL OF BIOTECHNOLOGY, 129, 290-307. ELSEVIER SCIENCE BV. https://doi.org/10.1016/j.jbiotec.2007.01.022
Lamanna, William C., Kalus, Ina, Padva, Michael, Baldwin, Rebecca J., Merry, Catherine L. R., and Dierks, Thomas. 2007. “The heparanome - The enigma of encoding and decoding heparan sulfate sulfation”. In Journal of Biotechnology, 129:290-307. JOURNAL OF BIOTECHNOLOGY. ELSEVIER SCIENCE BV.
Lamanna, W. C., Kalus, I., Padva, M., Baldwin, R. J., Merry, C. L. R., and Dierks, T. (2007). “The heparanome - The enigma of encoding and decoding heparan sulfate sulfation” in Journal of Biotechnology JOURNAL OF BIOTECHNOLOGY, vol. 129, (ELSEVIER SCIENCE BV), 290-307.
Lamanna, W.C., et al., 2007. The heparanome - The enigma of encoding and decoding heparan sulfate sulfation. In Journal of Biotechnology. JOURNAL OF BIOTECHNOLOGY. no.129 ELSEVIER SCIENCE BV, pp. 290-307.
W.C. Lamanna, et al., “The heparanome - The enigma of encoding and decoding heparan sulfate sulfation”, Journal of Biotechnology, JOURNAL OF BIOTECHNOLOGY, vol. 129, ELSEVIER SCIENCE BV, 2007, pp.290-307.
Lamanna, W.C., Kalus, I., Padva, M., Baldwin, R.J., Merry, C.L.R., Dierks, T.: The heparanome - The enigma of encoding and decoding heparan sulfate sulfation. Journal of Biotechnology. JOURNAL OF BIOTECHNOLOGY. 129, p. 290-307. ELSEVIER SCIENCE BV (2007).
Lamanna, William C., Kalus, Ina, Padva, Michael, Baldwin, Rebecca J., Merry, Catherine L. R., and Dierks, Thomas. “The heparanome - The enigma of encoding and decoding heparan sulfate sulfation”. Journal of Biotechnology. ELSEVIER SCIENCE BV, 2007.Vol. 129. JOURNAL OF BIOTECHNOLOGY. 290-307.

92 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Sulfatase 2 promotes generation of a spinal cord astrocyte subtype that stands out through the expression of Olig2.
Ohayon D, Escalas N, Cochard P, Glise B, Danesin C, Soula C., Glia 67(8), 2019
PMID: 30980466
Novel Insights into the Pathogenesis of Monogenic Congenital Anomalies of the Kidney and Urinary Tract.
van der Ven AT, Vivante A, Hildebrandt F., J Am Soc Nephrol 29(1), 2018
PMID: 29079659
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.
Nagarajan A, Malvi P, Wajapeyee N., Front Endocrinol (Lausanne) 9(), 2018
PMID: 30197623
Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.
Veraldi N, Parra A, Urso E, Cosentino C, Locatelli M, Corsini S, Pedrini E, Naggi A, Bisio A, Sangiorgi L., Molecules 23(12), 2018
PMID: 30544937
The function of heparan sulfate during branching morphogenesis.
Patel VN, Pineda DL, Hoffman MP., Matrix Biol 57-58(), 2017
PMID: 27609403
Glycosaminoglycanomics: where we are.
Ricard-Blum S, Lisacek F., Glycoconj J 34(3), 2017
PMID: 27900575
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M., Cancer Lett 393(), 2017
PMID: 28232049
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications.
Ayerst BI, Merry CLR, Day AJ., Pharmaceuticals (Basel) 10(2), 2017
PMID: 28608822
Binding Kinetics and Lateral Mobility of HSV-1 on End-Grafted Sulfated Glycosaminoglycans.
Peerboom N, Block S, Altgärde N, Wahlsten O, Möller S, Schnabelrauch M, Trybala E, Bergström T, Bally M., Biophys J 113(6), 2017
PMID: 28697896
Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell Signaling.
Roberts RO, Kang YN, Hu C, Moser CD, Wang S, Moore MJ, Graham RP, Lai JP, Petersen RC, Roberts LR., J Alzheimers Dis Rep 1(1), 2017
PMID: 30035253
Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation.
Okada T, Keino-Masu K, Nagamine S, Kametani F, Ohto T, Hasegawa M, van Kuppevelt TH, Kunita S, Takahashi S, Masu M., Sci Rep 7(1), 2017
PMID: 29062064
Mechanisms of FGF gradient formation during embryogenesis.
Balasubramanian R, Zhang X., Semin Cell Dev Biol 53(), 2016
PMID: 26454099
Advances in Understanding Hair Growth.
Bernard BA., F1000Res 5(), 2016
PMID: 26918186
The role of heparan sulphate in development: the ectodermal story.
Coulson-Thomas VJ., Int J Exp Pathol 97(3), 2016
PMID: 27385054
Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer.
Couchman JR, Multhaupt H, Sanderson RD., F1000Res 5(), 2016
PMID: 27408707
Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck.
Flowers SA, Zhou X, Wu J, Wang Y, Makambi K, Kallakury BV, Singer MS, Rosen SD, Davidson B, Goldman R., Oncotarget 7(28), 2016
PMID: 27223083
Regulation of Hedgehog Signalling Inside and Outside the Cell.
Ramsbottom SA, Pownall ME., J Dev Biol 4(3), 2016
PMID: 27547735
Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
Kumagai S, Ishibashi K, Kataoka M, Oguro T, Kiko Y, Yanagida T, Aikawa K, Kojima Y., Cancer Sci 107(11), 2016
PMID: 27589337
SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis.
Singer MS, Phillips JJ, Lemjabbar-Alaoui H, Wang YQ, Wu J, Goldman R, Rosen SD., Clin Chim Acta 440(), 2015
PMID: 25444749
Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.
Suhovskih AV, Domanitskaya NV, Tsidulko AY, Prudnikova TY, Kashuba VI, Grigorieva EV., Cell Adh Migr 9(6), 2015
PMID: 26120938
Catch bond interaction between cell-surface sulfatase Sulf1 and glycosaminoglycans.
Harder A, Möller AK, Milz F, Neuhaus P, Walhorn V, Dierks T, Anselmetti D., Biophys J 108(7), 2015
PMID: 25863062
A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.
Seneff S, Davidson RM, Lauritzen A, Samsel A, Wainwright G., Theor Biol Med Model 12(), 2015
PMID: 26014131
Heparan sulfate and heparin interactions with proteins.
Meneghetti MC, Hughes AJ, Rudd TR, Nader HB, Powell AK, Yates EA, Lima MA., J R Soc Interface 12(110), 2015
PMID: 26289657
Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.
Kalus I, Rohn S, Puvirajesinghe TM, Guimond SE, Eyckerman-Kölln PJ, Ten Dam G, van Kuppevelt TH, Turnbull JE, Dierks T., PLoS One 10(10), 2015
PMID: 26448642
Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis.
Lu J, Auduong L, White ES, Yue X., Am J Respir Cell Mol Biol 50(1), 2014
PMID: 23962103
Marine medicinal glycomics.
Pomin VH., Front Cell Infect Microbiol 4(), 2014
PMID: 24524028
Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer.
Suhovskih AV, Tsidulko AY, Kutsenko OS, Kovner AV, Aidagulova SV, Ernberg I, Grigorieva EV., Front Oncol 4(), 2014
PMID: 24782989
Production methods for heparosan, a precursor of heparin and heparan sulfate.
Chavaroche AA, van den Broek LA, Eggink G., Carbohydr Polym 93(1), 2013
PMID: 23465899
Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.
Wang C, Symington JW, Ma E, Cao B, Mysorekar IU., Infect Immun 81(3), 2013
PMID: 23264047
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
Fernández-Vega I, García O, Crespo A, Castañón S, Menéndez P, Astudillo A, Quirós LM., BMC Cancer 13(), 2013
PMID: 23327652
Role of heparan sulfatases in ovarian and breast cancer.
Khurana A, Beleford D, He X, Chien J, Shridhar V., Am J Cancer Res 3(1), 2013
PMID: 23359864
Overexpression of Sulf2 in idiopathic pulmonary fibrosis.
Yue X, Lu J, Auduong L, Sides MD, Lasky JA., Glycobiology 23(6), 2013
PMID: 23418199
Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.
Kim JH, Chan C, Elwell C, Singer MS, Dierks T, Lemjabbar-Alaoui H, Rosen SD, Engel JN., Cell Microbiol 15(9), 2013
PMID: 23480519
Artificial extracellular matrix composed of collagen I and highly sulfated hyaluronan interferes with TGFβ(1) signaling and prevents TGFβ(1)-induced myofibroblast differentiation.
van der Smissen A, Samsonov S, Hintze V, Scharnweber D, Moeller S, Schnabelrauch M, Pisabarro MT, Anderegg U., Acta Biomater 9(8), 2013
PMID: 23602877
Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
Milz F, Harder A, Neuhaus P, Breitkreuz-Korff O, Walhorn V, Lübke T, Anselmetti D, Dierks T., Biochim Biophys Acta 1830(11), 2013
PMID: 23891937
Arylsulfatase K, a novel lysosomal sulfatase.
Wiegmann EM, Westendorf E, Kalus I, Pringle TH, Lübke T, Dierks T., J Biol Chem 288(42), 2013
PMID: 23986440
Surface glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus salivarius Lv72.
Martín R, Martín C, Escobedo S, Suárez JE, Quirós LM., BMC Microbiol 13(), 2013
PMID: 24044741
3-OST-7 regulates BMP-dependent cardiac contraction.
Samson SC, Ferrer T, Jou CJ, Sachse FB, Shankaran SS, Shaw RM, Chi NC, Tristani-Firouzi M, Yost HJ., PLoS Biol 11(12), 2013
PMID: 24311987
SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.
Wall JS, Richey T, Stuckey A, Donnell R, Oosterhof A, van Kuppevelt TH, Smits NC, Kennel SJ., Nucl Med Biol 39(1), 2012
PMID: 21958847
Glycosaminoglycans from aged human hippocampus have altered capacities to regulate trophic factors activities but not Aβ42 peptide toxicity.
Huynh MB, Villares J, Díaz JE, Christiaans S, Carpentier G, Ouidja MO, Sissoeff L, Raisman-Vozari R, Papy-Garcia D., Neurobiol Aging 33(5), 2012
PMID: 22035591
Glycosylated synaptomatrix regulation of trans-synaptic signaling.
Dani N, Broadie K., Dev Neurobiol 72(1), 2012
PMID: 21509945
Structure/function analysis of Pasteurella multocida heparosan synthases: toward defining enzyme specificity and engineering novel catalysts.
Otto NJ, Green DE, Masuko S, Mayer A, Tanner ME, Linhardt RJ, DeAngelis PL., J Biol Chem 287(10), 2012
PMID: 22235128
Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.
Nagamine S, Tamba M, Ishimine H, Araki K, Shiomi K, Okada T, Ohto T, Kunita S, Takahashi S, Wismans RG, van Kuppevelt TH, Masu M, Keino-Masu K., J Biol Chem 287(12), 2012
PMID: 22298771
Roles of heparan sulfate sulfation in dentinogenesis.
Hayano S, Kurosaka H, Yanagita T, Kalus I, Milz F, Ishihara Y, Islam MN, Kawanabe N, Saito M, Kamioka H, Adachi T, Dierks T, Yamashiro T., J Biol Chem 287(15), 2012
PMID: 22351753
Harnessing glycomics technologies: integrating structure with function for glycan characterization.
Robinson LN, Artpradit C, Raman R, Shriver ZH, Ruchirawat M, Sasisekharan R., Electrophoresis 33(5), 2012
PMID: 22522536
Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.
Waaijer CJ, de Andrea CE, Hamilton A, van Oosterwijk JG, Stringer SE, Bovée JV., Virchows Arch 461(4), 2012
PMID: 22903264
Laser-capture microdissection and transcriptional profiling of the dorsomedial nucleus of the hypothalamus.
Lee S, Bookout AL, Lee CE, Gautron L, Harper MJ, Elias CF, Lowell BB, Elmquist JK., J Comp Neurol 520(16), 2012
PMID: 22473294
SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study.
Lui NS, van Zante A, Rosen SD, Jablons DM, Lemjabbar-Alaoui H., BMJ Open 2(6), 2012
PMID: 23180455
Heparan sulfate proteoglycans in healthy and diseased systems.
Whitelock J, Melrose J., Wiley Interdiscip Rev Syst Biol Med 3(6), 2011
PMID: 21462353
Heparan sulfate proteoglycans.
Sarrazin S, Lamanna WC, Esko JD., Cold Spring Harb Perspect Biol 3(7), 2011
PMID: 21690215
Exploring and exploiting chemistry at the cell surface.
Mager MD, LaPointe V, Stevens MM., Nat Chem 3(8), 2011
PMID: 21778976
DSulfatase-1 fine-tunes Hedgehog patterning activity through a novel regulatory feedback loop.
Wojcinski A, Nakato H, Soula C, Glise B., Dev Biol 358(1), 2011
PMID: 21806980
Is N-acetyl-D-glucosamine a rigid 4C1 chair?
Sattelle BM, Almond A., Glycobiology 21(12), 2011
PMID: 21807769
Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase.
Holley RJ, Deligny A, Wei W, Watson HA, Niñonuevo MR, Dagälv A, Leary JA, Bigger BW, Kjellén L, Merry CL., J Biol Chem 286(43), 2011
PMID: 21873421
Heparin: an intervenor in cell communication.
Xu X, Dai Y., J Cell Mol Med 14(1-2), 2010
PMID: 19659457
Proteolytic cleavage of the rat heparan sulfate 6-O-endosulfatase SulfFP2 by furin-type proprotein convertases.
Nagamine S, Keino-Masu K, Shiomi K, Masu M., Biochem Biophys Res Commun 391(1), 2010
PMID: 19900405
Characterizing molecular diffusion in the lens capsule.
Danysh BP, Patel TP, Czymmek KJ, Edwards DA, Wang L, Pande J, Duncan MK., Matrix Biol 29(3), 2010
PMID: 20026402
Expression patterns of sulfatase genes in the developing mouse embryo.
Ratzka A, Mundlos S, Vortkamp A., Dev Dyn 239(6), 2010
PMID: 20503373
TGF-β: Titan of Lung Fibrogenesis.
Yue X, Shan B, Lasky JA., Curr Enzym Inhib 6(2), 2010
PMID: 24187529
The lens capsule.
Danysh BP, Duncan MK., Exp Eye Res 88(2), 2009
PMID: 18773892
The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.
Teplyuk NM, Haupt LM, Ling L, Dombrowski C, Mun FK, Nathan SS, Lian JB, Stein JL, Stein GS, Cool SM, van Wijnen AJ., J Cell Biochem 107(1), 2009
PMID: 19259985
The signaling mechanisms of syndecan heparan sulfate proteoglycans.
Lambaerts K, Wilcox-Adelman SA, Zimmermann P., Curr Opin Cell Biol 21(5), 2009
PMID: 19535238
Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues: toward glycomics profiling.
Guimond SE, Puvirajesinghe TM, Skidmore MA, Kalus I, Dierks T, Yates EA, Turnbull JE., J Biol Chem 284(38), 2009
PMID: 19596853
Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.
Kirn-Safran C, Farach-Carson MC, Carson DD., Cell Mol Life Sci 66(21), 2009
PMID: 19629389
Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.
Frese MA, Milz F, Dick M, Lamanna WC, Dierks T., J Biol Chem 284(41), 2009
PMID: 19666466
Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity.
Kalus I, Salmen B, Viebahn C, von Figura K, Schmitz D, D'Hooge R, Dierks T., J Cell Mol Med 13(11-12), 2009
PMID: 20394677
Redundant function of the heparan sulfate 6-O-endosulfatases Sulf1 and Sulf2 during skeletal development.
Ratzka A, Kalus I, Moser M, Dierks T, Mundlos S, Vortkamp A., Dev Dyn 237(2), 2008
PMID: 18213582
Structural analysis of bikunin glycosaminoglycan.
Chi L, Wolff JJ, Laremore TN, Restaino OF, Xie J, Schiraldi C, Toida T, Amster IJ, Linhardt RJ., J Am Chem Soc 130(8), 2008
PMID: 18247611
Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo.
Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, Lasky JA., J Biol Chem 283(29), 2008
PMID: 18503048
Heparin dependent coiled-coil formation.
Nitz M, Rullo A, Ding MX., Chembiochem 9(10), 2008
PMID: 18506865
Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.
Lai JP, Thompson JR, Sandhu DS, Roberts LR., Future Oncol 4(6), 2008
PMID: 19086847
Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival.
Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, Chalasani S, Carano RA, Frantz GD, Tessier-Lavigne M, Bolon B, French DM, Ashkenazi A., PLoS One 2(6), 2007
PMID: 17593974

105 References

Daten bereitgestellt von Europe PubMed Central.

Hsulf-1 regulates growth and invasion of pancreatic cancer cells.
Abiatari I, Kleeff J, Li J, Felix K, Buchler MW, Friess H., J. Clin. Pathol. 59(10), 2006
PMID: 16603650
Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2.
Ai X, Do AT, Kusche-Gullberg M, Lindahl U, Lu K, Emerson CP Jr., J. Biol. Chem. 281(8), 2005
PMID: 16377625
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.
Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson CP Jr., J. Cell Biol. 162(2), 2003
PMID: 12860968
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S, Bernfield M., Nat. Genet. 25(3), 2000
PMID: 10888884
Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y., Nat. Genet. 23(3), 1999
PMID: 10545953
Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
Arikawa-Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, Hassell JR, Yamada Y., Nat. Genet. 27(4), 2001
PMID: 11279527
Functions of cell surface heparan sulfate proteoglycans.
Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M., Annu. Rev. Biochem. 68(), 1999
PMID: 10872465
Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development.
Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE., J. Biol. Chem. 273(8), 1998
PMID: 9468484
1.3 A structure of arylsulfatase from Pseudomonas aeruginosa establishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family.
Boltes I, Czapinska H, Kahnert A, von Bulow R, Dierks T, Schmidt B, von Figura K, Kertesz MA, Uson I., Structure 9(6), 2001
PMID: 11435113
Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase.
Bullock SL, Fletcher JM, Beddington RS, Wilson VA., Genes Dev. 12(12), 1998
PMID: 9637690
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J., J. Cell Biol. 146(1), 1999
PMID: 10402475
Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice.
Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R., Circ. Res. 91(2), 2002
PMID: 12142349
Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding.
Crown SE, Yu Y, Sweeney MD, Leary JA, Handel TM., J. Biol. Chem. 281(35), 2006
PMID: 16803905
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo.
Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z, Venkataraman G, Sasisekharan R, Sanderson RD., J. Biol. Chem. 280(48), 2005
PMID: 16192265
Developmental changes in heparan sulfate expression: in situ detection with mAbs.
David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H., J. Cell Biol. 119(4), 1992
PMID: 1385449
Structural determinants of heparan sulphate modulation of GDNF signalling.
Davies JA, Yates EA, Turnbull JE., Growth Factors 21(3-4), 2003
PMID: 14708939
Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements.
De Cat B, Muyldermans SY, Coomans C, Degeest G, Vanderschueren B, Creemers J, Biemar F, Peers B, David G., J. Cell Biol. 163(3), 2003
PMID: 14610063
Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.
Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH., J. Biol. Chem. 277(13), 2002
PMID: 11790764
Microarrays of heparin oligosaccharides obtained by nitrous acid depolymerization of isolated heparin.
de Paz JL, Spillmann D, Seeberger PH., Chem. Commun. (Camb.) (29), 2006
PMID: 16855704
Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase.
Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP Jr., Science 293(5535), 2001
PMID: 11533491
Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases.
Dierks T, Lecca MR, Schlotterhose P, Schmidt B, von Figura K., EMBO J. 18(8), 1999
PMID: 10205163
Sulfatases
Dierks, 2001
Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme.
Dierks T, Schmidt B, Borissenko LV, Peng J, Preusser A, Mariappan M, von Figura K., Cell 113(4), 2003
PMID: 12757705
Sulfatases and human disease.
Diez-Roux G, Ballabio A., Annu Rev Genomics Hum Genet 6(), 2005
PMID: 16124866
Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.
Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P., J. Clin. Invest. 107(2), 2001
PMID: 11160142
Molecular diversity of heparan sulfate.
Esko JD, Lindahl U., J. Clin. Invest. 108(2), 2001
PMID: 11457867
Heparin structure and interactions with basic fibroblast growth factor.
Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC., Science 271(5252), 1996
PMID: 8599088
Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice.
Fan G, Xiao L, Cheng L, Wang X, Sun B, Hu G., FEBS Lett. 467(1), 2000
PMID: 10664446
Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling.
Ford-Perriss M, Guimond SE, Greferath U, Kita M, Grobe K, Habuchi H, Kimata K, Esko JD, Murphy M, Turnbull JE., Glycobiology 12(11), 2002
PMID: 12460940
Heparan sulfate: lessons from knockout mice.
Forsberg E, Kjellen L., J. Clin. Invest. 108(2), 2001
PMID: 11457868
Multiprotein signalling complexes: regional assembly on heparan sulphate.
Gallagher JT., Biochem. Soc. Trans. 34(Pt 3), 2006
PMID: 16709181
Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature.
Gotte M, Joussen AM, Klein C, Andre P, Wagner DD, Hinkes MT, Kirchhof B, Adamis AP, Bernfield M., Invest. Ophthalmol. Vis. Sci. 43(4), 2002
PMID: 11923257
Dynamic biosynthesis of heparan sulphate sequences in developing mouse brain: a potential regulatory mechanism during development.
Guimond S, Turner K, Kita M, Ford-Perriss M, Turnbull J., Biochem. Soc. Trans. 29(Pt 2), 2001
PMID: 11356149
Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility.
Hanson SR, Best MD, Wong CH., Angew. Chem. Int. Ed. Engl. 43(43), 2004
PMID: 15493058
Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex.
Harmer NJ, Ilag LL, Mulloy B, Pellegrini L, Robinson CV, Blundell TL., J. Mol. Biol. 339(4), 2004
PMID: 15165853
Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin.
Harmer NJ, Robinson CJ, Adam LE, Ilag LL, Robinson CV, Gallagher JT, Blundell TL., Biochem. J. 393(Pt 3), 2006
PMID: 16223363
N-syndecan deficiency impairs neural migration in brain.
Hienola A, Tumova S, Kulesskiy E, Rauvala H., J. Cell Biol. 174(4), 2006
PMID: 16908672
Specific heparan sulfate structures involved in retinal axon targeting.
Irie A, Yates EA, Turnbull JE, Holt CE., Development 129(1), 2002
PMID: 11782401
Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions.
Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Tsuzuki S, Nakamura E, Kusugami K, Saito H, Muramatsu T., J. Biol. Chem. 275(8), 2000
PMID: 10681494
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma.
Jayson GC, Vives C, Paraskeva C, Schofield K, Coutts J, Fleetwood A, Gallagher JT., Int. J. Cancer 82(2), 1999
PMID: 10389767
Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.
Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH., J. Neurosci. 20(11), 2000
PMID: 10818145
Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system.
Kamimura K, Fujise M, Villa F, Izumi S, Habuchi H, Kimata K, Nakato H., J. Biol. Chem. 276(20), 2001
PMID: 11278892
Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling.
Kamimura K, Koyama T, Habuchi H, Ueda R, Masu M, Kimata K, Nakato H., J. Cell Biol. 174(6), 2006
PMID: 16966419
Direct isolation and sequencing of specific protein-binding glycosaminoglycans.
Keiser N, Venkataraman G, Shriver Z, Sasisekharan R., Nat. Med. 7(1), 2001
PMID: 11135627
The function of a Drosophila glypican does not depend entirely on heparan sulfate modification.
Kirkpatrick CA, Knox SM, Staatz WD, Fox B, Lercher DM, Selleck SB., Dev. Biol. 300(2), 2006
PMID: 17055473
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.
Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR, Shridhar V., J. Biol. Chem. 278(25), 2003
PMID: 12686563
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.
Lai JP, Chien J, Strome SE, Staub J, Montoya DP, Greene EL, Smith DI, Roberts LR, Shridhar V., Oncogene 23(7), 2004
PMID: 14973553
hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.
Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP, Matthews TA, Nagorney DM, Cunningham JM, Smith DI, Greene EL, Shridhar V, Roberts LR., Gastroenterology 126(1), 2004
PMID: 14699503
SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, Murphy LM, Garrity-Park MM, Shridhar V, Adjei AA, Roberts LR., Gastroenterology 130(7), 2006
PMID: 16762634
Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity.
Lamanna WC, Baldwin RJ, Padva M, Kalus I, Ten Dam G, van Kuppevelt TH, Gallagher JT, von Figura K, Dierks T, Merry CL., Biochem. J. 400(1), 2006
PMID: 16901266
The elusive functions of proteoglycans: in vivo veritas.
Lander AD, Selleck SB., J. Cell Biol. 148(2), 2000
PMID: 10648554
Heparan sulfate structure in mice with genetically modified heparan sulfate production.
Ledin J, Staatz W, Li JP, Gotte M, Selleck S, Kjellen L, Spillmann D., J. Biol. Chem. 279(41), 2004
PMID: 15292174
When sugars guide axons: insights from heparan sulphate proteoglycan mutants.
Lee JS, Chien CB., Nat. Rev. Genet. 5(12), 2004
PMID: 15573124
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.
Li J, Kleeff J, Abiatari I, Kayed H, Giese NA, Felix K, Giese T, Buchler MW, Friess H., Mol. Cancer 4(1), 2005
PMID: 15817123
Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice.
Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM., Dev. Biol. 224(2), 2000
PMID: 10926768

AUTHOR UNKNOWN, 0
Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.
Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT., J. Biol. Chem. 269(15), 1994
PMID: 8157651
Domain structure of heparan sulfates from bovine organs.
Maccarana M, Sakura Y, Tawada A, Yoshida K, Lindahl U., J. Biol. Chem. 271(30), 1996
PMID: 8663266

AUTHOR UNKNOWN, 0
The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse.
Merry CL, Bullock SL, Swan DC, Backen AC, Lyon M, Beddington RS, Wilson VA, Gallagher JT., J. Biol. Chem. 276(38), 2001
PMID: 11457822
Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer.
Morimoto-Tomita M, Uchimura K, Bistrup A, Lum DH, Egeblad M, Boudreau N, Werb Z, Rosen SD., Neoplasia 7(11), 2005
PMID: 16331886
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans.
Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD., J. Biol. Chem. 277(51), 2002
PMID: 12368295
A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase.
Murphy KJ, Merry CL, Lyon M, Thompson JE, Roberts IS, Gallagher JT., J. Biol. Chem. 279(26), 2004
PMID: 15047699
HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V., Cancer Res. 66(12), 2006
PMID: 16778174
Modular synthesis of heparin oligosaccharides.
Orgueira HA, Bartolozzi A, Schell P, Litjens RE, Palmacci ER, Seeberger PH., Chemistry 9(1), 2003
PMID: 12506372
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL., Nature 407(6807), 2000
PMID: 11069186
Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.
Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT., J. Biol. Chem. 273(36), 1998
PMID: 9722514
Structural insights into biological roles of protein-glycosaminoglycan interactions.
Raman R, Sasisekharan V, Sasisekharan R., Chem. Biol. 12(3), 2005
PMID: 15797210
Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1.
Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, Eriksson I, Olofsson AM, Kjellen L, Forsberg E., J. Biol. Chem. 275(34), 2000
PMID: 10852901
VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.
Robinson CJ, Mulloy B, Gallagher JT, Stringer SE., J. Biol. Chem. 281(3), 2005
PMID: 16258170
Regulation of vascular smooth muscle cell proliferation, migration and death by heparan sulfate 6-O-endosulfatase1.
Sala-Newby GB, George SJ, Bond M, Dhoot GK, Newby AC., FEBS Lett. 579(28), 2005
PMID: 16289059
Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship.
Sardiello M, Annunziata I, Roma G, Ballabio A., Hum. Mol. Genet. 14(21), 2005
PMID: 16174644
Glycomics approach to structure-function relationships of glycosaminoglycans.
Sasisekharan R, Raman R, Prabhakar V., Annu Rev Biomed Eng 8(), 2006
PMID: 16834555
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M., Mol. Cell 6(3), 2000
PMID: 11030354
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase.
Scholefield Z, Yates EA, Wayne G, Amour A, McDowell W, Turnbull JE., J. Cell Biol. 163(1), 2003
PMID: 14530380
Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.
Shworak NW, HajMohammadi S, de Agostini AI, Rosenberg RD., Glycoconj. J. 19(4-5), 2002
PMID: 12975616
Attachment of glycosaminoglycan oligosaccharides to thiol-derivatised gold surfaces.
Skidmore MA, Patey SJ, Thanh NT, Fernig DG, Turnbull JE, Yates EA., Chem. Commun. (Camb.) (23), 2004
PMID: 15568074
Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
Stickens D, Zak BM, Rougier N, Esko JD, Werb Z., Development 132(22), 2005
PMID: 16236767
Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry.
Sweeney MD, Yu Y, Leary JA., J. Am. Soc. Mass Spectrom. 17(8), 2006
PMID: 16735126
Heparan sulfate: decoding a dynamic multifunctional cell regulator.
Turnbull J, Powell A, Guimond S., Trends Cell Biol. 11(2), 2001
PMID: 11166215
HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.
Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, Gallagher J, Werb Z, Rosen SD., BMC Biochem. 7(), 2006
PMID: 16417632
Heparan sulfate proteoglycans and the emergence of neuronal connectivity.
Van Vactor D, Wall DP, Johnson KG., Curr. Opin. Neurobiol. 16(1), 2006
PMID: 16417999
Sequencing complex polysaccharides.
Venkataraman G, Shriver Z, Raman R, Sasisekharan R., Science 286(5439), 1999
PMID: 10521350
Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin.
Viviano BL, Paine-Saunders S, Gasiunas N, Gallagher J, Saunders S., J. Biol. Chem. 279(7), 2003
PMID: 14645250
A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease.
von Figura K, Schmidt B, Selmer T, Dierks T., Bioessays 20(6), 1998
PMID: 9699462
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.
Wang S, Ai X, Freeman SD, Pownall ME, Lu Q, Kessler DS, Emerson CP Jr., Proc. Natl. Acad. Sci. U.S.A. 101(14), 2004
PMID: 15051888
Heparan sulfate: a complex polymer charged with biological activity.
Whitelock JM, Iozzo RV., Chem. Rev. 105(7), 2005
PMID: 16011323
Protein-GAG interactions: new surface-based techniques, spectroscopies and nanotechnology probes.
Yates EA, Terry CJ, Rees C, Rudd TR, Duchesne L, Skidmore MA, Levy R, Thanh NT, Nichols RJ, Clarke DT, Fernig DG., Biochem. Soc. Trans. 34(Pt 3), 2006
PMID: 16709178
Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
Zimmermann P, Zhang Z, Degeest G, Mortier E, Leenaerts I, Coomans C, Schulz J, N'Kuli F, Courtoy PJ, David G., Dev. Cell 9(3), 2005
PMID: 16139226
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 17337080
PubMed | Europe PMC

Suchen in

Google Scholar